Explore the April issue of PME, featuring the $150bn GLP-1 weight loss market and the race for oral obesity medications. This edition covers critical challenges in tuberculosis treatment adherence and the groundbreaking use of CAR-T cell therapies for lupus, an autoimmune condition disproportionately affecting women and ethnic minority groups. Stay ahead with the latest in pharmaceutical innovation and clinical breakthroughs.




































